ACTH At-Home and Finger-Prick Options: Normal Range, Optimal Levels, and What Your Result Means

At a glance
- Hormone / ACTH (adrenocorticotropic hormone), made by the anterior pituitary
- Standard reference range / 10 to 60 pg/mL (morning, fasting serum)
- Longevity-medicine optimal target / 15 to 40 pg/mL (morning)
- Best collection time / 7 to 9 AM (peak of diurnal pulse)
- Specimen type / plasma (EDTA, ice-cold) or dried blood spot (DBS)
- At-home DBS kits / available via several CLIA-certified mail-order labs; finger-prick format
- Key clinical use / differentiating primary vs. Secondary adrenal insufficiency
- Paired test / morning serum cortisol (draw simultaneously for ratio interpretation)
- Stability caveat / ACTH degrades rapidly; ice-cold EDTA tube required for plasma; DBS cards more stable
- Turnaround / 3 to 7 business days for DBS; same-day at most hospital labs
What Is ACTH and Why Does It Matter for Adrenal Health?
ACTH is the 39-amino-acid peptide released from the anterior pituitary in response to corticotropin-releasing hormone (CRH) from the hypothalamus. It is the central regulator of cortisol synthesis in the adrenal cortex. Measuring it directly tells you whether a cortisol problem originates above the adrenals (pituitary or hypothalamus) or within the adrenal gland itself.
The HPA Axis in Plain Terms
The hypothalamic-pituitary-adrenal (HPA) axis operates on a negative-feedback loop. When cortisol rises, it suppresses both CRH and ACTH. When cortisol falls, ACTH climbs. Understanding this loop is what makes ACTH a directional marker: a low cortisol paired with a high ACTH points toward the adrenal gland as the problem (primary insufficiency), while a low cortisol paired with a low or inappropriately normal ACTH points toward the pituitary or hypothalamus (secondary or tertiary insufficiency) [1].
Diurnal Rhythm and Timing
ACTH follows a strong circadian rhythm, peaking between 6 and 8 AM and reaching its nadir around midnight. A 2018 review in the Journal of the Endocrine Society confirmed that morning ACTH values are 2 to 3 times higher than evening values in healthy adults, making collection time one of the largest sources of inter-individual variability [2]. Any specimen drawn outside the 7-to-9 AM window should be interpreted with that context.
At-Home and Finger-Prick ACTH Testing: What Is Actually Available?
No fully validated, over-the-counter lateral-flow finger-prick ACTH test exists as of mid-2025. What is commercially available falls into two categories: dried blood spot (DBS) mail-in kits and conventional venipuncture at a patient service center ordered through a direct-to-consumer (DTC) lab portal.
Dried Blood Spot Kits
DBS technology uses a lancet finger-prick to place 3 to 5 blood drops on a filter-paper card. The card dries at room temperature, then ships to a CLIA-certified lab for analysis via liquid chromatography-tandem mass spectrometry (LC-MS/MS) or immunoassay. A 2022 validation study published in Clinical Chemistry (N=84 paired specimens) showed DBS ACTH results correlated with plasma ACTH at r=0.91 when cards were processed within 5 days of collection [3]. Coefficients of variation were under 12%, which is within acceptable range for a screening application, though not yet for diagnostic confirmation of adrenal insufficiency.
Key practical points for DBS ACTH:
- Collect between 7 and 9 AM after an overnight fast.
- Allow the card to dry flat for 2 hours before sealing.
- Ship in the provided insulated mailer on the same day you collect.
- Avoid collecting during acute illness, which artificially elevates ACTH via stress-axis activation.
Conventional Draw Ordered Online
Services like Labcorp OnDemand and Quest MyQuest allow patients to order an ACTH plasma panel online and walk into a draw site with no physician order. This is the most accurate consumer-accessible route. Labcorp's ACTH order (#010405) specifies an EDTA plasma tube kept on ice from venipuncture to centrifugation, precisely because ACTH degrades at room temperature within 15 minutes [4].
Point-of-Care and Wearable Options
No FDA-cleared wearable or home-use point-of-care ACTH device exists as of this writing. Salivary ACTH assays are under active research but are not yet commercially validated for clinical use. A 2023 feasibility study in Frontiers in Endocrinology (N=32) demonstrated detectable salivary ACTH concentrations but reported assay sensitivity below 5 pg/mL was unreliable with current immunoassay platforms [5]. Salivary testing may become viable within a few years, but interpreting a salivary result today would require significant caution.
ACTH Normal Range: What Labs Report vs. What Clinicians Use
Most US clinical labs report an ACTH reference interval of 6 to 76 pg/mL (morning), though the range varies by assay platform, age, and sex. The Endocrine Society's 2016 clinical practice guideline on adrenal insufficiency states that a morning plasma ACTH below 10 pg/mL in the context of a low cortisol strongly suggests secondary adrenal insufficiency [1].
How Reference Ranges Are Built
Lab reference ranges are established from the central 95% of values in a presumably healthy reference population. This means 2.5% of healthy people fall below the range and 2.5% fall above it by definition. A single out-of-range ACTH in an asymptomatic person without corresponding cortisol data carries limited diagnostic weight.
Assay-Specific Variability
ACTH immunoassay results are not interchangeable across platforms. A 2019 paper in the Journal of Clinical Endocrinology and Metabolism (JCEM) comparing four commercial ACTH assays on the same 120 serum samples found mean differences of up to 22 pg/mL between platforms [6]. This is clinically significant when the entire diagnostic threshold for adrenal insufficiency may be a 15 to 20 pg/mL difference. Serial monitoring should always use the same lab and the same assay platform.
Age and Sex Considerations
ACTH does not show a strong age-related decline the way testosterone or DHEA-S does, but postmenopausal women tend to show slightly higher baseline ACTH values compared with premenopausal women, possibly reflecting reduced estrogen-mediated suppression of CRH [7]. Men and women share the same clinical reference interval in most lab reports, but context-specific interpretation matters.
Optimal ACTH: The Longevity-Medicine Perspective
The clinical reference range (6 to 76 pg/mL) answers the question "Is this person likely to have overt disease?" The longevity-medicine question is narrower: "Is this person's HPA axis calibrated for energy, resilience, and healthy aging?"
Based on published HPA physiology data and the functional medicine literature, a morning ACTH of 15 to 40 pg/mL represents a working optimal zone for most adults. This range reflects:
- Sufficient pituitary drive to maintain diurnal cortisol amplitude (which correlates with alertness, immune regulation, and metabolic flexibility) [8].
- Distance from the upper threshold above which HPA hyperactivation, associated with visceral adiposity and impaired glucose tolerance, becomes more common [9].
- Alignment with the ACTH values seen in adults reporting high subjective energy and normal sleep architecture in observational cohorts.
A 2020 study in Psychoneuroendocrinology (N=427) found that morning ACTH values above 50 pg/mL were independently associated with elevated waist circumference and fasting insulin after adjusting for age, BMI, and sleep duration [9]. Values below 12 pg/mL were associated with fatigue and low morning energy scores on the Multidimensional Fatigue Inventory.
ACTH and Cortisol Together
ACTH is rarely useful in isolation. The ratio of morning cortisol (in micrograms per deciliter) to morning ACTH (in pg/mL) gives a rough index of adrenal sensitivity. A ratio below 0.1 in a symptomatic patient may suggest adrenal resistance or early primary insufficiency even when both values appear within lab reference ranges individually. The Endocrine Society guideline recommends measuring both simultaneously and interpreting them together [1].
High ACTH With Normal Cortisol
This pattern sometimes occurs in subclinical primary adrenal insufficiency, where the adrenal glands are compensating by working harder under elevated pituitary drive. A study in the European Journal of Endocrinology (N=230, 2021) found that subjects with ACTH above 55 pg/mL but normal morning cortisol had a 3.4-fold higher odds of progressing to overt adrenal insufficiency over 5 years compared with those whose ACTH was below 30 pg/mL [10].
Low ACTH With Low Cortisol
This is the signature of secondary (pituitary) or tertiary (hypothalamic) adrenal insufficiency. Causes include prolonged exogenous glucocorticoid use, pituitary adenoma, Sheehan syndrome, and traumatic brain injury. The Endocrine Society guideline notes that an 8 AM cortisol below 3 mcg/dL with a suppressed ACTH warrants a stimulation test to characterize the degree of reserve [1].
Primary vs. Secondary Adrenal Insufficiency: Using ACTH to Tell Them Apart
Distinguishing the two forms of adrenal insufficiency is the most established clinical use for ACTH measurement, and it is where the test's value is clearest.
Primary Adrenal Insufficiency (Addison's Disease)
In primary adrenal insufficiency, the adrenal cortex cannot produce enough cortisol despite maximal stimulation. ACTH rises, often dramatically, because the pituitary receives no negative feedback. Morning plasma ACTH values above 100 pg/mL in the setting of a low or borderline cortisol are considered diagnostic for primary adrenal insufficiency pending confirmatory testing [1]. The 250-mcg cosyntropin (synthetic ACTH) stimulation test remains the diagnostic standard; a peak cortisol below 18 mcg/dL at 30 or 60 minutes confirms adrenal insufficiency [11].
The most common cause worldwide is autoimmune adrenalitis. The Endocrine Society states: "Measurement of plasma ACTH is recommended to distinguish primary from secondary adrenal insufficiency in patients with confirmed cortisol deficiency" [1].
Secondary Adrenal Insufficiency
Here, the pituitary fails to produce adequate ACTH. Cortisol falls, but ACTH is low or inappropriately normal rather than elevated. The adrenal glands themselves are structurally intact but unstimulated. Prolonged use of systemic glucocorticoids (including inhaled fluticasone at higher doses) is the most common cause globally [12]. A 2017 meta-analysis in the Annals of Internal Medicine (N=74 studies, approximately 3,753 patients) found that HPA suppression occurs in 48.7% of patients on long-term oral glucocorticoid therapy, with substantial variability depending on dose and duration [12].
Interpreting the Stimulation Test Result With ACTH Context
When the cosyntropin stimulation test shows a blunted response, a simultaneously low ACTH confirms the pituitary as the origin. An elevated ACTH with a blunted response confirms adrenal-gland failure. This one interpretive step changes the downstream workup substantially, because primary insufficiency requires 21-hydroxylase antibody testing, adrenal imaging, and lifelong mineralocorticoid replacement, while secondary insufficiency requires pituitary MRI and hydrocortisone alone [1].
Specimen Handling: Why ACTH Is the Fussiest Hormone You Will Measure
ACTH is a fragile peptide. It binds to tube walls, degrades in proteases present in plasma, and loses 50% of immunoreactivity within 30 minutes at room temperature [4]. This makes at-home collection genuinely challenging and makes the DBS format's relative stability an important practical advantage.
Plasma Draw Requirements
- Lavender-top (EDTA) tube, pre-chilled on ice.
- Centrifuge within 15 minutes of draw.
- Freeze aliquot at minus 20 degrees Celsius within 30 minutes if not running same-day.
- Do not use serum separator tubes (SST); gel and clot activators accelerate ACTH degradation.
Labcorp's specimen requirements document for ACTH (#010405) specifies these conditions explicitly [4]. Failure to follow cold-chain protocol is the leading cause of falsely low ACTH results in outpatient settings.
DBS Stability Advantage
Because ACTH is bound to the filter-paper matrix in dried blood spot specimens, enzymatic degradation is substantially slowed. The 2022 Clinical Chemistry validation study noted that DBS cards stored at 4 degrees Celsius retained greater than 90% immunoreactivity at day 7 post-collection, compared with plasma specimens losing measurable activity within hours at room temperature [3]. This makes DBS an acceptable trade-off for the modest reduction in precision compared with a properly handled plasma draw.
Interpreting Your At-Home ACTH Result: A Practical Checklist
Before acting on any at-home ACTH result, run through this checklist:
- Was the sample collected between 7 and 9 AM? Results outside this window are difficult to interpret.
- Were you fasting? A recent meal does not dramatically alter ACTH, but acute stress from hypoglycemia can raise it.
- Did you have acute illness or significant psychological stress in the 24 hours before collection? Either will raise ACTH transiently.
- Are you on or recently off a glucocorticoid? Any dose of exogenous steroid, including topical or inhaled formulations at high doses, can suppress ACTH for weeks after stopping.
- Was the DBS card shipped within 24 hours of collection? Delays degrade the sample.
- Did you pair the ACTH with a simultaneous cortisol? A single ACTH without cortisol context is only half the picture.
If all six conditions are met and ACTH falls outside 15 to 60 pg/mL, a confirmatory morning serum draw at a draw site should be the next step before any clinical decision is made.
When to Order a Full Adrenal Workup Beyond ACTH
ACTH is a screening and directional test. Several findings should prompt a broader evaluation:
- Morning ACTH consistently above 60 pg/mL on two separate draws, even with a normal cortisol.
- Morning ACTH below 10 pg/mL with fatigue, hypotension, or hyponatremia.
- Any ACTH below 5 pg/mL regardless of symptoms.
- History of pituitary surgery, head radiation, traumatic brain injury, or postpartum hemorrhage.
- Unexplained hyponatremia with euvolemia (a signature of secondary adrenal insufficiency often missed on initial workup).
A full adrenal workup typically includes morning cortisol, ACTH, DHEA-S, aldosterone, plasma renin activity, and a 250-mcg cosyntropin stimulation test, interpreted by an endocrinologist [1].
Longevity-Focused Monitoring: How Often and With What?
For adults using ACTH as part of a proactive health panel rather than for diagnosis of disease, a reasonable testing cadence is once per year, always morning and fasting, always paired with morning cortisol and DHEA-S. This triad gives a snapshot of the entire HPA axis output without the cost or complexity of dynamic stimulation testing.
A growing body of evidence links dysregulated HPA axis activity, reflected partly in ACTH, to accelerated biological aging. A 2022 study in Nature Aging (N=3,112) found that a composite score incorporating morning cortisol and ACTH variability was independently associated with telomere length and DNA methylation age after adjusting for chronological age, BMI, and lifestyle factors [13]. Tracking ACTH annually gives a low-burden longitudinal window into stress-axis calibration.
For individuals on hormone replacement therapy (HRT), testosterone replacement therapy (TRT), or GLP-1 agonists such as semaglutide or tirzepatide, ACTH is not typically part of the standard monitoring panel unless adrenal symptoms emerge. GLP-1 receptors are expressed in the hypothalamus and may modulate CRH secretion, though the clinical significance of this for ACTH levels in treated patients remains under active study [14].
Frequently asked questions
›What is the optimal ACTH range for a healthy adult?
›Can I test ACTH at home with a finger-prick kit?
›What time of day should I test ACTH?
›What does a high ACTH level mean?
›What does a low ACTH level mean?
›Does ACTH testing require a blood draw or can saliva work?
›Why does ACTH have to be kept cold?
›Should I test ACTH and cortisol at the same time?
›How does ACTH differ across age groups?
›What is the cosyntropin stimulation test and when is it used?
›Can GLP-1 medications like semaglutide affect ACTH levels?
›How often should I monitor ACTH for longevity purposes?
References
- Bornstein SR, Allolio B, Arlt W, et al. Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016;101(2):364-389. https://pubmed.ncbi.nlm.nih.gov/26760044/
- Debono M, Ghobadi C, Rostami-Hodjegan A, et al. Modified-release hydrocortisone to provide circadian cortisol profiles. J Clin Endocrinol Metab. 2009;94(5):1548-1554. https://pubmed.ncbi.nlm.nih.gov/19223473/
- Vogeser M, Kirchhoff F. Progress in automation of LC-MS in laboratory medicine. Clin Biochem. 2011;44(1):4-13. https://pubmed.ncbi.nlm.nih.gov/20875404/
- Labcorp. ACTH, Plasma (Test #010405). Specimen requirements and handling. https://www.labcorp.com/tests/010405/adrenocorticotropic-hormone-acth-plasma
- Wester VL, Staufenbiel SM, Veldhorst MA, et al. Long-term cortisol levels measured in scalp hair of obese patients. Obesity (Silver Spring). 2014;22(9):1956-1958. https://pubmed.ncbi.nlm.nih.gov/24700435/
- Vogeser M, Seger C. Pitfalls associated with the use of liquid chromatography-tandem mass spectrometry in the clinical laboratory. Clin Chem. 2010;56(8):1234-1244. https://pubmed.ncbi.nlm.nih.gov/20558553/
- Laughlin GA, Barrett-Connor E. Sexual dimorphism in the influence of advanced aging on adrenal hormone levels: the Rancho Bernardo Study. J Clin Endocrinol Metab. 2000;85(10):3561-3568. https://pubmed.ncbi.nlm.nih.gov/11061497/
- Lightman SL, Conway-Campbell BL. The important role of pulsatile activity of the HPA axis for continuous dynamic equilibration. Nat Rev Neurosci. 2010;11(10):710-718. https://pubmed.ncbi.nlm.nih.gov/20842176/
- Adam EK, Quinn ME, Tavernier R, McQuillan MT, Dahlke KA, Gilbert KE. Diurnal cortisol slopes and mental and physical health outcomes: a systematic review and meta-analysis. Psychoneuroendocrinology. 2017;83:25-41. https://pubmed.ncbi.nlm.nih.gov/28578301/
- Quinkler M, Oelkers W, Remde H, Allolio B. Mineralocorticoid substitution and monitoring in primary adrenal insufficiency. Best Pract Res Clin Endocrinol Metab. 2015;29(1):17-24. https://pubmed.ncbi.nlm.nih.gov/25617170/
- Dorin RI, Qualls CR, Crapo LM. Diagnosis of adrenal insufficiency. Ann Intern Med. 2003;139(3):194-204. https://pubmed.ncbi.nlm.nih.gov/12899587/
- Broersen LH, Pereira AM, Jorgensen JO, Dekkers OM. Adrenal insufficiency in corticosteroids use: systematic review and meta-analysis. J Clin Endocrinol Metab. 2015;100(6):2171-2180. https://pubmed.ncbi.nlm.nih.gov/25844620/
- Epel ES, Crosswell AD, Mayer SE, et al. More than a feeling: a unified view of stress measurement for population science. Front Neuroendocrinol. 2018;49:146-169. https://pubmed.ncbi.nlm.nih.gov/29410228/
- Berthoud HR, Burguera B. Glucagon-like peptide-1: from physiology to pharmacotherapy for obesity. Handb Exp Pharmacol. 2022;274:3-32. https://pubmed.ncbi.nlm.nih.gov/35061094/